Study of the prevalence of autoimmune thyroid disease in women with breast cancer

Endocrine Practice

Volumn 22, Issue 1, 2016, Pages 16-21

  Freitas, Paula Andréa V C J ^a   Vissoci, Gisele M ^a   Pinto, Rogério M ^a   Lajolo, Paula P ^a   Jorge, Paulo T ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BRAZIL; BREAST NEOPLASMS; CASE CONTROL STUDY; COMPLICATION; ECHOMAMMOGRAPHY; FEMALE; HUMAN; MAMMOGRAPHY; MIDDLE AGED; PREVALENCE; THYROID FUNCTION TEST; THYROIDITIS, AUTOIMMUNE;

ADULT; AGED; BRAZIL; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PREVALENCE; THYROID FUNCTION TESTS; THYROIDITIS, AUTOIMMUNE; ULTRASONOGRAPHY, MAMMARY;

EID: 84982969332     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP14445.OR     Document Type: Article

References (30)

1. Repert RW. Breast carcinoma study: relation to thyroid disease and diabetes. J Mich State Med Soc. 1952;51: 1315-1316.
2. Sommers SC. Endocrine abnormalities in women with breast cancer. Lab Invest. 1955;4:160-174.
3. Ellerker AG. Thyroid disorders and breast cancer: a causal connection. Med Press. 1956;235:280-282.
4. Perry M, Goldie DJ, Self M. Thyroid function in patients with breast cancer. Ann R Coll Surg Engl. 1978;60:290-293.
5. Smyth PP, Smith DF, McDermott EW, Murray MJ, Geraghty JG, O'Higgins NJ. A direct relationship between thyroid enlargement and breast cancer. J Clin Endocrinol Metab. 1996;81:937-941.
6. Giani C, Fierabracci P, Bonacci R, et al. Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab. 1996;81:990-994.
7. Dulger H, Alici S, Algun E, Etlik O, Sayarlioglu M, Dogan E. Antithyroid antibody levels with breast cancer. Eur J Gen Med. 2004;1:11-14.
8. Smyth PP, Shering SG, Kilbane MT, et al. Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma. J Clin Endocrinol Metab. 1998;83: 2711-2716.
9. Giustarini E, Pinchera A, Fierabracci P, et al. Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol. 2006;154: 645-649.
10. Turken O, Narln Y, Demlrbas S, et al. Breast cancer in association with thyroid disorders. Breast Cancer Res. 2003;5:R110-R113.
11. MacFarlane IA, Robinson EL, Bush H, et al. Thyroid function in patients with benign and malignant breast disease. Br J Cancer. 1980;41:478-480.
12. Pearce SH, Brabant G, Duntas LH, et al. 2013 ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J. 2013;2:215-228.
13. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18: 988-1028.
14. Hammond ME, Hayes DF, Dowsett M, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohisto-chemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med. 2010;134:e48-e72.
15. Michalaki V, Kondi-Pafiti A, Gennatas S, Antoniou A, Primetis H, Gennatas C. Breast cancer in association with thyroid disorders. J Buon. 2009;14:425-428.
16. Sarlis NJ, Gourgiotis L, Pucino F, Tolis GJ. Lack of association between Hashimoto thyroiditis and breast cancer: a quantitative research synthesis. Hormones (Athens). 2002; 1:35-41.
17. Feibelmann TC, Gonçalves FT, Daud MS, Jorge Ade S, Mantese SA, Jorge PT. Assessment of association between autoimmune thyroid disease and chronic urticarial [in Portuguese]. Arq Bras Endocrinol Metabol. 2007;51: 1077-1083.
18. Gonçalves FT, Feibelmann TCM, Ranza R, et al. Autoimmune thyroiditis and rheumatoid arthritis: is there really an association? Endocrinologist. 2009;19:31-34.
19. Santos SRX, Ferreira MS, Borges AS, Pinto RDMC, Fernandes MLPM, Jorge PT. Thyroid disorders in hepatitis C patients treated or not with α-interferon and ribavi-rin. Endocrinologist. 2010;20:122-124.
20. Cengiz O, Bozkurt B, Unal B, et al. The relationship between prognostic factors of breast cancer and thyroid disorders in Turkish women. J Surg Oncol. 2004;87:19-25.
21. Gogas J, Kouskos E, Tseleni-Balafouta S, et al. Autoimmune thyroid disease in women with breast carcinoma. Eur J Surg Oncol. 2001;27:626-630.
22. Saraiva PP, Figueiredo NB, Padovani CR, Brentani MM, Nogueira CR. Profile of thyroid hormones in breast cancer patients. Braz J Med Biol Res. 2005;38:761-765.
23. Lai LC. Role of steroid hormones and growth factors in breast cancer. Clin Chem Lab Med. 2002;40:969-974.
24. Silva JM, Domínguez G, Gonzáles-Sancho JM, et al. Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer. Oncogene. 2002;21: 4307-4316.
25. Shao Z, Sheikh MS, Rishi AH, et al. Thyroid hormone enhancement of estradiol stimulation of breast carcinoma proliferation. Exp Cell Res. 1995;218:1-8.
26. Nogueira CR, Brentani MM. Triiodothyronine mimics the effects of estrogen in breast cancer cell lines. J Steroid Biochem Mol Biol. 1996;59:271-279.
27. Dohán O, De la Vieja A, Paroder V, et al. The sodium/ iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev. 2003;24:48-77.
28. Miki H, Oshimo K, Inoue H, Morimoto T, Monden Y. Sex hormone receptors in human thyroid tissues. Cancer. 1990;66:1759-1762.
29. Tavangar SM, Monajemzadeh M, Larijani B, Haghpanah V. Immunohistochemical study of oestrogen receptors in 351 human thyroid glands. Singapore Med J. 2007;48:744-747.
30. Hardefeldt PJ, Eslick GD, Edirimanne S. Benign thyroid disease is associated with breast cancer: a meta-analysis. Breast Cancer Res Treat. 2012;133:1169-1177.